Clinical Trials on 挫伤手腕或手 in Finland
总计505个结果
-
Tampere University HospitalRegionshospitalet Viborg, Skive; Central Finland Hospital District; Satakunta Central Hospital完全的
-
Remedy Pharmaceuticals, Inc.终止
-
Töölö HospitalTurku University Hospital; Tampere University Hospital; Jyväskylä Central Hospital; Kymenlaakso...招聘中
-
Bonalive Biomaterials LtdTurku University Hospital主动,不招人
-
University of TurkuHelsinki University Central Hospital; University of California, Irvine完全的
-
Niuvanniemi HospitalKarolinska Institutet撤销
-
Helsinki University Central HospitalUniversity of Helsinki; Tampere University; Aalto University招聘中
-
Zealand University HospitalCopenhagen Trial Unit, Center for Clinical Intervention Research; Scandinavian Critical Care... 和其他合作者主动,不招人
-
Johnson & Johnson Consumer Inc. (J&JCI)Infinant Health, Inc. (formerly known as Evolve BioSystems, Inc.)主动,不招人
-
Hospital District of Helsinki and Uusimaa主动,不招人
-
Helsinki University Central HospitalThe Swedish Research Council完全的
-
AstraZeneca终止Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC芬兰
-
Turku University HospitalMead Johnson Nutrition; Academy of Finland完全的
-
Inha University HospitalTurku University Hospital完全的
-
University of OuluBayer; Kuopio University Hospital; Tampere University完全的怀孕 | 先兆子痫 | 宫内胎儿生长受限 | Miscarriage Less Than 12 Gestational Weeks | Extrauterine Pregnancy芬兰
-
Helsinki University Central HospitalTurku University Hospital; Tampere University完全的
-
Kuopio University HospitalUniversity of Eastern Finland招聘中
-
Kuopio University HospitalUniversity of Eastern Finland招聘中
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLC招聘中铂耐药卵巢癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 铂类难治性输卵管癌 | 铂类难治性原发性腹膜癌 | 铂类难治性卵巢癌 | 参与者对卡铂和/或顺铂过敏或严重不耐受的铂敏感性卵巢癌 | 参与者对卡铂和/或顺铂过敏或严重不耐受的铂敏感性输卵管癌 | 参与者对卡铂和/或顺铂过敏或严重不耐受的铂敏感原发性腹膜癌美国, 芬兰